Real-World Treatment Patterns, Clinical Outcomes, and Symptom Burden in Patients With Psoriatic Arthritis Prescribed Ixekizumab in the United States.

Rohekar, Sherry; Vadhariya, Aisha; Ross, Sarah; Malatestinic, William; Janos, Boris; Massey, Nicola; Hughes, Megan; Weatherby, Sarah; Birt, Julie; Sebba, Anthony

Rohekar, Sherry; Vadhariya, Aisha; Ross, Sarah; Malatestinic, William; Janos, Boris; Massey, Nicola; Hughes, Megan; Weatherby, Sarah; Birt, Julie; Sebba, Anthony.

Afiliación

Rohekar S; Western University, London, Ontario, Canada.
Vadhariya A; Eli Lilly and Company, Indianapolis, Indiana.
Ross S; Eli Lilly and Company, Indianapolis, Indiana.
Malatestinic W; Eli Lilly and Company, Indianapolis, Indiana.
Janos B; Eli Lilly and Company, Indianapolis, Indiana.
Massey N; Adelphi Real World, Bollington, United Kingdom.
Hughes M; Adelphi Real World, Bollington, United Kingdom.
Weatherby S; Adelphi Real World, Bollington, United Kingdom.
Birt J; Eli Lilly and Company, Indianapolis, Indiana.
Sebba A; University of South Florida, Tampa, Florida.

ACR Open Rheumatol ; 6(7): 440-449, 2024 Jul.

Article en En | MEDLINE | ID: mdl-38705580

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: ACR Open Rheumatol Año: 2024 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google